CELLIVERY

R&D

INTELLECTUAL PROPRIETARY

"Cellivery is Patentee"

# Target Indication and Use Application Number Date Registration Number/
Date
01 aMTDs aMTD/TSDT Platform
[PCT/KR2015/008544]
CN (201580044116.8) 17.02.16
JP (2017-510405) 17.02.15 6559227 (19.08.14)
US (15/503117) 17.02.10 10323063 (19.06.18)
CA (2957501) 17.02.07
KR (10-2017-7005079) 17.02.22 101971021 (19.04.23)
EP (15833496.1) 17.02.13
AU (2015304194) 17.01.12 2015304194 (18.03.01)
02 iCP-SOCS3
Pancreatic Cancer Therapy
[PCT/KR2016/009416]
EP (16839623.2) 18.03.13
US (15/408123) 17.01.17
Solid Tumor Therapy
[PCT/KR2016/009414]
EP (16839621.6) 18.03.15
US (15/361701) 16.11.28
Anti-Angiogenesis Therapy
[PCT/KR2016/009456]
EP (16839637.2) 18.03.16
US (15/631982) 17.06.23
Hepatocellular Carcinoma Therapy
[PCT/KR2016/009446]
US (15/432662) 17.02.14 10385103 (19.08.20)
Lung Cancer Therapy
[PCT/KR2016/009441]
US (15/408230) 17.01.17
03 iCP-Parkin Parkinson's Disease Therapy
[PCT/KR2016/008174]
CN (201680044600.5) 18.04.03
JP (2018-503759) 18.01.25
US (15/879664) 18.01.25
CA (2993778) 18.01.25
KR (10-2018-7005889) 18.02.27
EP (16830820.3) 18.02.27 등록완료/등록번호 미정
AU (2016299468) 18.01.17 2016299468(19.07.25)
IN (201827002920) 18.01.24
04 CP-BMP2 Bone Healing Therapy
[PCT/KR2016/009405]
EP (16839619.0) 18.03.12
US (15/884884) 18.01.31 등록완료/등록번호 미정
05 CP-△SOCS3 Obesity Therapy
[PCT/KR2016/008831]
EP (16837265.4) 18.03.07
US (15/888459) 18.02.05 10323072 (19.06.18)
06 iCP-Cre Genome Engineering Enzyme
[PCT/KR2016/008760]
EP (16835419.9) 18.03.02
US (15/887414) 18.02.02
07 iCP-RFs iPSC Reprogramming Factors
[PCT/KR2016/008757]
EP (16835416.5) 18.03.02 등록완료/등록번호 미정
US (15/884651) 18.01.31 등록완료/등록번호 미정
08 CP-Cas9 Genome Editing Enzyme
[PCT/KR2017/010747]
EP (17856752.5) 19.03.14
US (16/337250) 19.03.27